跳至主要内容
临床试验/ISRCTN43520960
ISRCTN43520960已完成未知

Comparative effectiveness of prolotherapy regenerative injection technique with conventional treatment to treat recalcitrant supraspinatus tendinosis in human subjects: a randomised controlled trial

niversity of Malaya (Malaysia)0 个研究点目标入组 20 人开始时间: 2013年2月5日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 18 to 65 years
  • 2. Able to understand completely the study procedure
  • 3. Symptomatic tendinopathy > 6 months
  • 4. Failure of the following conservative modalities: relative rest, physiotherapy, non-steroidal anti-inflammatory drugs and two corticosteroid injection

排除标准

  • 1. Autoimmune Diseases such as Rheumatoid Arthritis etc
  • 2. Patients on anticoagulant such as Warfarin, unless written consent is obtained from the attending physician
  • 3. Congenital or Acquired Platelet Dysfunction abnormality/disorder e.g. von Willebrand Disease, Glanzmann Disease etc
  • 4. Haemoglobin level less than 10G/L and/or Platelet count less than 100,000/uL
  • 5. Diabetes
  • 6. Corticosteroid injection within the past 6 weeks
  • 7. Self-reported immuno-compromised status

研究者

发起方
niversity of Malaya (Malaysia)

相似试验

Comparative effectiveness of prolotherapy... | 临床试验